KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Investing Activities: 2017-2025

Historic Cash from Investing Activities for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$24.8 million.

  • Twist Bioscience's Cash from Investing Activities fell 865.21% to -$12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.8 million, marking a year-over-year decrease of 706.32%. This contributed to the annual value of -$24.8 million for FY2025, which is 706.32% down from last year.
  • As of FY2025, Twist Bioscience's Cash from Investing Activities stood at -$24.8 million, which was down 706.32% from -$3.1 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Cash from Investing Activities ranged from a high of $156.2 million in FY2021 and a low of -$232.9 million during FY2022.
  • In the last 3 years, Twist Bioscience's Cash from Investing Activities had a median value of -$3.1 million in 2024 and averaged $7.6 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 236.20% in 2021, then plummeted by 706.32% in 2025.
  • Over the past 5 years, Twist Bioscience's Cash from Investing Activities (Yearly) stood at $156.2 million in 2021, then crashed by 249.17% to -$232.9 million in 2022, then soared by 121.73% to $50.6 million in 2023, then slumped by 106.07% to -$3.1 million in 2024, then slumped by 706.32% to -$24.8 million in 2025.